跳至主要内容
临床试验/NCT02229643
NCT02229643已完成不适用

Neuroglobin and Nogo-A as Biomarkers for the Prognosis of Closed Traumatic Brain Injury

Shanghai 6th People's Hospital1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2012年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
34
试验地点
1
主要终点
Glasgow Outcome Scale scores

研究概览

简要总结

Neuroglobin has been described as a marker of traumatic brain injury. Nogo-A plays an important role in mediating neuroanatomical plasticity and functional recovery following traumatic brain injury. The investigators sought to examine the changes in serum neuroglobin and Nogo-A concentrations in patients with traumatic brain injury during the initial 96-h posttraumatic period and assessed the relation of neuroglobin and Nogo-A to Glasgow Coma Score and prognosis of such patients with traumatic brain injury.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who suffered head trauma and whose highest abbreviated injury score (AIS) was 3 or less (other than head injury)
  • Patients who delivered to hospital within 4 h

排除标准

  • Patients who suffered open injuries
  • Patients who had existing prior neurological disease
  • Patients whose serial serum samples could not be obtained
  • Patients less than 18 years of age
  • Patients who suffered severe life-threatening injury to organs other than the brain

结局指标

主要结局

Glasgow Outcome Scale scores

时间窗: 6 months

Glasgow Outcome Scale 1 = death; Glasgow Outcome Scale 2 = vegetative state; Glasgow Outcome Scale 3 = severe neurological deficit; Glasgow Outcome Scale 4 = mild neurological deficit and Glasgow Outcome Scale 5 = premorbid level of functioning or completely recovery. Unfavorable outcome was defined as a Glasgow Outcome Scale score of ≤ 3, and favorable outcome was defined as a Glasgow Outcome Scale score of \> 3.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hao Chen

Doctor

Shanghai 6th People's Hospital

研究点 (1)

Loading locations...

相似试验